Details for New Drug Application (NDA): 212046
✉ Email this page to a colleague
NDA 212046 describes DIHYDROERGOTAMINE MESYLATE, which is a drug marketed by Baxter Hlthcare Corp, Cipla, Gland, Hikma, Hikma Pharms, Milla Pharms, Padagis Us, Sagent Pharms Inc, Amneal, Rubicon Research, and Somerset Theraps Llc, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the DIHYDROERGOTAMINE MESYLATE profile page.
The generic ingredient in DIHYDROERGOTAMINE MESYLATE is dihydroergotamine mesylate. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
The generic ingredient in DIHYDROERGOTAMINE MESYLATE is dihydroergotamine mesylate. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
Summary for 212046
| Tradename: | DIHYDROERGOTAMINE MESYLATE |
| Applicant: | Milla Pharms |
| Ingredient: | dihydroergotamine mesylate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 212046
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 212046 | ANDA | Provepharm Inc. | 81284-411 | 81284-411-05 | 5 AMPULE in 1 CARTON (81284-411-05) / 1 mL in 1 AMPULE (81284-411-00) |
| DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 212046 | ANDA | Provepharm Inc. | 81284-411 | 81284-411-10 | 10 AMPULE in 1 CARTON (81284-411-10) / 1 mL in 1 AMPULE (81284-411-00) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Jan 7, 2020 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
